Genexine Inc.

Genexine Inc. is a South Korean biotech using hybrid‑Fc and DNA vaccine platforms to develop immunotherapies. Pipeline: Phase II/III candidates GX‑H9 & GX‑188E, plus Binex COVID‑19 vaccine, targeting high‑growth markets.

Headquarters: South Korea (KOR)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Hospitals and Health Care
Industry: Medical and Diagnostic Laboratories

Employees: 86
HQ: Seoul

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
095700	Genexine Inc. Cap: 221.5B	EQUITY	KOE	KRW	KR7095700001	Active	📈